Life Science Business Consulting

Introduction

Features

Related Courses

About Life Science Consulting

Life Science Consulting training

This online Lifesceience business consulting course provides hands on training to enhance skill competency of Lifesceience consultant.

This course ideal for the professionals who are working or planning to shift into pharmaceutical and biopharmaceutical consulting domain.

Life Science Consulting course includes training of pharmaceutical, Biopharmaceutical and Medical Device industry.

Life Science and Healthcare Consulting primarily focus on advising for pharmaceutical and medical device companies/products. There are many capabilities specific to each company but broad ones can include:

Pharmaceutical, Biopharmaceutical and Medical Device Launch Excellence – Discovery, Development to commercialization.
Forecasting and Valuation, In and Outlicensing.
Brand Acquisition and Company Acquisition
Market Research with physicians and payers.
Pharmacoeconomics and HEOR.
Drug Pricing and Reimbursement optimization.
Sales Force and Market Access strategic planning.
Pharmacovigilance and Safety Management.
Medical Device Market Access.
Medical Device Strategic Planning – Regulation, Registration, Market Insights.

Moreover, this comprehensive Life Science Consulting training involves the real life job simulation. Hence, the course provides practical knowledge. Moreover, this course focuses on how pharma business development, strategic management, regulatory and licensing professionals working in the company. Therefore, it helps advance professionals to acquire cutting edged life sciences business consulting skills.

Above all, this is ideal course which provides participants understanding about the development to commercialization process in detail. In other words, you will understand portfolio strategic management. Hence, the course covers fundamentals to advance learning on various skill areas.

Who should attend this course?

Those who are in the working in Life Science Consulting Domain. Hence this course provides training for those who are already working in the Life Science Consulting domain.
Also this course will be ideal for the professional who are in consulting business but want to work into Life Science Consulting.
Moreover, this course is ideal choice for the professionals who want to join in Life Science Consulting.

Key details about the course:

Course Code: RYD-114
Title of the course: Executive PG Certification in Life Science Business Consulting [PGLSCON]
Type of the course: Self paced Online Course. Hence, this course can be accessed online across anywhere 24×7. Moreover, you can attend the course at your convenience in your flexible time. For example, you want to attend the session at your 11 pm at night, you can do that.
Duration of the course: 1 Year. Course can completed within 1 year based on own speed of access.
Course Certificate: Certificate will be provided at the end of the successful completion of the course
Top Performer of the course : Click here to view

Features of Life Science Consulting Business Training Course

This course covers all aspects of the strategic management from drug discovery development, regulatory, commercialization, market access, pricing and various other domains where life science consultants work day to day basis.
Hence this course provides orientation to job related practical aspects of the Life Science Consultants. Therefore, on completion of the course, the participants will develop the hands on understanding how Life Science Consulting Professionals works.
Moreover the course provides real life simulation on critical decision making process. Therefore, these simulations help to enhance the licensing and decision making skills which is the core aspects of the Life Science Consulting working.

Case Based Learning

Advance training on drug and biologics discovery, development to commercialization.
Course provides hands on training on portfolio management skills including market access, forecasting and valuations.
Access to Case Studies to learn about the drug commercialization steps. Hence, participants will develop advanced competency on strategic portfolio management.

Few of the similar courses

What is Life Science Consulting?

Life science consulting is a specialized field of consulting that focuses on providing strategic, operational, regulatory, and scientific expertise to businesses and organizations operating in the life sciences industry. In fact, the life sciences industry encompasses a wide range of sectors, including pharmaceuticals, biotechnology, medical devices, healthcare, and biopharmaceuticals. Life science consultants assist clients in navigating the complex and highly regulated landscape of these industries to achieve their business goals and improve their overall performance.

Life science consulting firms often comprise interdisciplinary teams of experts, including scientists, regulatory specialists, business analysts, and healthcare professionals. These teams work collaboratively to address the unique challenges and opportunities within the life science sector, helping clients achieve their objectives while ensuring compliance with industry-specific regulations and standards. Hence, Life science consulting is integral to the success and growth of companies in this highly regulated and dynamic field.

Section 1Pharma R&D Management- Discovery to Development | Strategic Management for US Market

Lecture 1R&D Process & Introduction to drug discovery

Lecture 2Investigational New Drug Application (INDA)

Lecture 3New Drug Application (NDA)

Lecture 4Basic concept and understanding of the Generic Drug

Lecture 5Abbreviated New Drug Application (ANDA)

Lecture 7Abbreviated Biosimilar Application - 351(k): Advance Strategic Planning Process : Originator Vs. Biosimilar Development and Regulatory Approval Process | Reference Biologic | Purple Book | Data Requirements

Lecture 8Purple Book: Significance | Searching | Assignments

Lecture 9Handling of orange book

Lecture 10USFDA expedited programs

Lecture 11Practical Training on INDA, NDA, ANDA filing

Lecture 12505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA

Lecture 13Authorized Generics: Key Understanding

Lecture 14Exploratory IND Vs. Traditional IND

Lecture 15Patents Vs. exclusivity

Lecture 16Orphan Drug Designation

Lecture 17Advance Learning on 505B2 Pathway

Lecture 18Chemistry, Manufacturing & Controls

Lecture 21Clinical Trial Protocol Writing

Lecture 22Ethics in Clinical Research

Lecture 23Informed Consent | Practical Training on preparing ICF | Ready Templates

Lecture 24FDA Forms and How to fill the resources

Lecture 25Strategic Discussion: PreIND, EOP1, EOP2 - What to expect !

Lecture 26Importance and Significance of Phase 2b Clinical Trial

Lecture 27Regulatory Strategies in different phases of Clinical Trial

Lecture 28Para IV Filing - Strategic Insight

Lecture 29Para IV Notices

Lecture 30Evergreening - Patent Life Extension Strategies

Lecture 31Pay For Delay Strategy

Lecture 32REMS Strategic Planning

Lecture 33Compulsory Licensing

Lecture 34Licensing & Technology Transfer

Lecture 35In-Licensing Vs. Outlicensing

Lecture 36LOE Strategies for Innovator Brands with case study

Lecture 37Pediatric Exclusivity and Pediatric Study Plan Development

Lecture 38Drug Repurposing

Lecture 39Advance understanding of the portfolio Management

Lecture 40New Indication Approval Process and Promotion

Lecture 41OTC Switch

Lecture 42Detailed Understanding on 505(b)(2) VS. Suitability Petition : Case Based Learning

Lecture 43NCE Vs. 505b2 application - Case Based Learning

Lecture 44FTF - 180 Days Exclusivity - Case Based Learning

Lecture 45Classic case study of the 505b2 filing : Case Based Learning

Lecture 46Strategic Planning in Combating 30 months stay strategies of innovator company- Case Based Learning

Lecture 47What is meaning of 'Pipeline in a Molecule'?

Lecture 48USFDA Emergency Use Authorization (EUA)

Lecture 49Target product profile (TPP) | Quality Target product profile (QTPP) | Critical Quality Attributes (CQAs) | Quality By Design (QbD)

Lecture 50Fundamental of CMC | Detailed understanding of CMC section writing | Important Points regarding CMC | Drug Product and Drug Substance | Excipient, FP, Analysis and Stability Study Requirements

Lecture 51Review on Drug Discovery and Development

Section 2Strategic Business Management - European Market

Lecture 52Introduction to EU Regulation

Lecture 53Orientation to European Countries and National Regulatory Bodies

Lecture 54EU Drug Discovery Development to Commercialization (Step By Step)

Lecture 55Overview of EU Regulation

Lecture 56EMA and EMA Authorisation Process

Lecture 57EU MA Application Types and Strategic Planning

Lecture 58EU MA Procedure - Centralised, Decentralised, Mutual Recognition, National Procedure

Lecture 59EU MA Strategic Planning: Full, Full-mixed, hybrid applications. Generic, Similar biologic application pathway, Well-established use application, Fixed combination application, Informed consent application

Lecture 60Validity of the EU MA - Renewal steps, Cessation of the marketing authorisation, Significance of "Placed in Union Market", Suspension or withdrawal & EU MA for licensed products

Lecture 61Data Exclusivity and Market Protection - Supplementary Patent Protection, Exclusivity, 6/10 Rule, 8+2+1 Formulae

Lecture 62EU Orphan Medicinal Products Regulation

Lecture 63Conditional marketing authorisation | Marketing authorisation under exceptional circumstances

Lecture 64Summary of Product Characteristics

Lecture 65Compassionate Use

Lecture 66The 'sunset clause' for marketing authorisation of pharmaceuticals

Lecture 67Paediatric use marketing authorisation (PUMA) & Paediatric Investigation Plan (PIP) - EU Requirments

Lecture 68EU Prime Designation

Lecture 69Accelerated assessment by EMEA

Lecture 70EU Adaptive Pathway

Section 3HEOR, Market Access & Pricing, Reimbursement, Forecasting

Lecture 71Introduction to Market Access | Objectives | Various Key Terminologies | Steps of Market Access | Understanding on Pricing and Reimbursement

Lecture 72Market Access Functions : Role and Responsibilities | Key Job Areas | Understanding Job Description

Lecture 73Introduction to Health Economics | Key terminologies related to health economics.

Lecture 74HEOR Application in Pharmaceutical and Biopharmaceutical Industry

Lecture 76Economic Evaluation Methods | Various methods | Importance of perspective in health economics | Discounting | Uncertainty

Lecture 81Patient Based Forecasting Model | Applying more filters and variables

Lecture 82QALY | How to calculate QALY | Importance and Significance

Lecture 83ICER | How to calculate ICER | Importance and Significance | Incremental Effectiveness determination

Lecture 84CER and PCOR

Lecture 85Market Access Strategic Planning : Steps and Logical Sequencing for Market Access Strategy Development

Lecture 86Indication Sequencing | Indication Prioritization | Development of Indication Timeline | Indication Matrix | Value Based Indication Prioritization

Lecture 87Market Access Value Dossier : What it is | Significance | Components | What to include

Lecture 88AMCP Market Access Dossier Preparation

Lecture 89Target product profile (TPP) | Quality Target product profile (QTPP) | Critical Quality Attributes (CQAs) | Quality By Design (QbD)

Lecture 90Drug Pricing Methodologies - I

Lecture 91Drug Pricing Methodologies - II

Lecture 93Pharma Market Access Pricing Case Study: interchangeable Pricing

Lecture 94Sales Forecasting in Life Science Industry

Lecture 95New Product Forecast Algorithm

Lecture 96Patient Based Forecasting Model | Applying more filters and variables

Lecture 97Prescription Based Forecasting Model | Differences between Patient Based and Prescription Based Forecasting Model | Which model to use and when?

Lecture 98Prevalence Vs. Incidence Model

Lecture 99EPI Based Forecasting | Sales Based Forecasting | When and where to apply which forecasting model

Lecture 100Sales Forecasting Tools | New Product Forecasting | In Market Forecasting

Lecture 101Market Size Assignment 1 [Oncology Brand] - Applying sales forecasting tools to carry out next 6 years sales forecast | Excel Based Model

Lecture 102Market Size Assignment 2 [Asthma Brand] - Applying sales forecasting tools to carry out multiple years sales forecast | Excel Based Model

Lecture 103Patient Based Model Vs. Patient Flow Model | Critical Differences in Model | Concept of Black Box in Patient Flow Model | Application of both model

Lecture 104Concomitancy and polypharmacy | How it alter the basic forecasting algorithm | Practical Working | Comorbidity

Lecture 106Bottom-up or Top-down Forecasting | LRx | Significance of LRx data analysis

Lecture 107Simulation on Bottom-up forecasting

Lecture 108Assessment on Bottom-up forecasting

Lecture 109Oncology Brand Forecasting

Lecture 110Revenue Forecasting Case Study - Novel Antihypertensive

Lecture 111Portfolio Based Forecasting | Forecasting Model Development in Excel

Lecture 112Evidence Based Decision Making | Combine evidences for decision making | Do we need more evidence?

Lecture 113RWD and RWE | Potential sources of RWE | Traditional RCTs vs. RWE | Case Study - RWE Programs | Influencing HCP decision-making

Lecture 114RWD and RWE in Product Lifecycle Management

Lecture 115RWD and RWE - Fit to use | Assessment

Lecture 116RWD data sources | Different types | Detailed understanding of each class

Lecture 117First-in-class | Best-in-class | Market Access Strategic Decision Making

Lecture 118Forecasting Biosimilar | Key Factors to consider

Lecture 119Consensus Meeting

Lecture 120One Number Vs. Multi Number Forecasting

Lecture 121Active Vs. Passive Cannibalization | Impact on forecasting | Case Study

Lecture 122Rebates | Importance | Factors affecting Rebates | Deductibles and Rebates

Lecture 124Treatment Algorithm and Forecasting : Case Based Learning

Lecture 125Chronic and Acute Segment | Forecasting on Chronic and Acute Segment Drugs

Lecture 126Prescription Value Calculation

Section 4Branding & Brand Management

Lecture 127Marketing Orientation

Lecture 128Why Is Market Research Important in Pharmaceutical Business?

Lecture 129Market Research - Customer Engagement through feedback mechanism

Lecture 130Product Life cycle

Lecture 131Advance - Strategic Planning in Product Life cycle Management

Lecture 132Segmentation, Targeting and Positioning

Lecture 133A Pharmaceutical Segmentation outlook

Lecture 134Distribution Channel in Pharmaceutical Industry

Lecture 135Promotion in Pharmaceutical Industry : Communication Model, Effective promotional communication, Push Vs. Pull Strategy and Buying Decision Process

Lecture 136Practical understanding on Prescription Accelerating Materials used in pharmaceutical promotion

Lecture 137Method of Promotional Budgeting

Lecture 138Brand Recall | Brand Recognition |Top of mind - How to calculate brand recall value?

Lecture 139Advertising - Introduction | Objective | Types of Advertising

Lecture 140ATL, BTL & TTL Advertising

Lecture 141Advertising Agency - Understanding on various types of advertising agency

Lecture 142Selection of Advertising Agency

Lecture 143What is creative Briefing? How to Prepare !

Lecture 144Creative Briefing - Practical Simulation

Lecture 145Request for Proposal | Concepts in advertising

Lecture 146Advertising Message Strategy Development and Evaluation

Lecture 147Creative Approach and Styles

Lecture 148Steps of Development of Creatives

Lecture 149Advertisement Copy Development

Lecture 150How to prepare Ad Campaign Step By Step

Lecture 151Brand Name | Brand Logo | Designing of Brand Logo | Trademarking

Lecture 152Advance Understanding of Pharmaceutical Brand Logo Development

Lecture 153Component of Brand Logo

Lecture 154Brand Name and Trademark Registration Process

Lecture 155Trademark Searching Process | Hands on Practical Training

Lecture 156How to design an excellent brand logo : Tricks of the trade

Lecture 157Logo colour theme | Colour system | Colour coding | Significance of colour

Lecture 158Few Case Studies related to brand names and logos

Lecture 159Can one innovator company keep 2 or more brand name?

Lecture 160Traditional Vs. Non-Traditional trademark | Significance of Colour in Pharma Branding

Lecture 161Global Trademarking : Brand Protection Globally

Lecture 162Logo Rebranding - Reasons | Practical Examples | How to handle logo rebranding | Forced Rebranding

Lecture 163Brand Logo Development: Real Life Simulation

Lecture 164Tagline - Development, Finalization and Protection

Lecture 165Pharma Brand Name Generator

Lecture 166Fundamental of Pharma Marketing Plan

Lecture 167Basic Understanding how to launch a pharmaceutical product into the market

Lecture 168Practical Training on Marketing Plan Preparation with real life example

Lecture 169Marketing Campaign Development : Importance of Target Audience Segmentation for effective targeting

Lecture 170Sample Marketing Plan

Lecture 171Decide about brand USP -What to promote

Lecture 172How to prepare promotogram. Download sample Promotogram

Lecture 173Importance and Handling of Cycle Meeting and its importance

Lecture 174Sample Marketing Plan

Lecture 175Sample Marketing Plan

Lecture 176Sample Marketing Plan

Lecture 177CSR Campaign

Lecture 178Increase the brand reach with advance segmentation

Lecture 179Concept of uniform branding for better brand acceptability

Lecture 180Concept of Brand Differentiation

Lecture 181Introduction to visual aid designing | V3M Concept | Components of the visual aid page

Lecture 182Practical Training in visual aid designing | Step By Step Visual Aid Preparation | Creative Designing | Guideline on Proofing | USPs to differentiate the visual aid

Lecture 183Visual Aid Printing | Establishing Visual Aid Printing Specs for effective management of the vendors

Lecture 184Visual Aid Analysis with practical example

Lecture 185Guideline on visual aid development

Lecture 186Marketing Plan followed by Visual Aid Development

Lecture 187Visual Aid, Literature reference Sample

Lecture 188Interactive Visual Aid | E-detailing | Remote Detailing | Analysis of Animated Video based e-detailing visual aids

Lecture 189Visual aid detailing story writing

Lecture 190Artwork Development Process in PMT Department

Lecture 191Product List and Reminder card development

Lecture 192Catch Cover Development

Lecture 193Packaging Development

Lecture 194Prescribing Information and Patient Information Leaflet development

Lecture 195Pharma Packaging Case Studies

Lecture 196DHCP letter

Lecture 197Product Packshot Designing : Practical Knowledge

Lecture 198Creativity to develop brand essence

Lecture 199Advance Training on Pharmaceutical Packaging - Creative Packaging for Brand Differentiation

Lecture 200Unique identifier & anti-tampering device on outer packaging

Section 5Licensing and Valuation

Lecture 201Training on Basic Finance | Understanding Financial Statment | Income Statement | Balance Sheet | Cash Flow Statement

Lecture 202Moving Average | Moving Annual Total | YTD | How to calculate

Lecture 203Compound Annual Growth Rate | CAGR Calculation

Lecture 204Business Development Job Functionality | Strategic Planning Process | Knowledge Area of Business Development | Lead targeting | Licensing term sheets

Lecture 205Portfolio Management Process | Portfolio Characteristics | Portfolio Analysis | Balancing the Portfolio | BD and Strategic Planning Department

Lecture 206Identifying the corporate Need of business development | Objective – Strategy - Tactics | Portfolio constraints | SWOT | Numerical SWOT

Lecture 208Numerical SWOT Practical training

Lecture 210Market Size Determination - Market Share | Relative Market Share | Total Vs. Actual Vs. Penetrated Market

Lecture 211Forecasting : Tools and Techniques

Lecture 212Market Sizing & Forecasting Case Study

Lecture 214Average Royalty Rate

Lecture 215Factor affecting the Royalty Rate in Pharmaceutical and Biopharmaceutical Deal

Lecture 216Distribution Licensing | Geography | Indication Splitting | Exclusive and Non-Exclusive Licensing | Sub Licenses

Lecture 218Joint Ventures in Pharmaceutical and Biopharmaceutical Industry

Lecture 219SPECIAL PURPOSE VEHICLES (SPV)

Lecture 220Indication Splitting | Concept | Implementation feasibility analysis

Lecture 221Types of Deals from Discovery to Commercialization

Lecture 222What are the fundamental areas of business development

Lecture 223Licensing Term Sheet | Content Structuring | Sample Term Sheet

Lecture 224Licensing Payment Scheduling: Different Types

Lecture 226Valuation Methods: EBITDA method of valuation | Enterprise Value and Enterprise Multiple Calculation

Lecture 227Negotiation Skill Training for BD personnel | Mind Mapping Tools | Practical Case Based Learning | Do and Don’ts in Pharma Business development Negotiations | Role of Scribes

Lecture 228Business Development Simulation and Decision Making | Early Stage VS. Late Stage Valuation Methodology | Stair Step Model

Lecture 230Benchmarking | Benchmarking through consortium | How to use benchmarking for drug discovery development projects

Section 6Biopharmaceutical Management and Regulation

Lecture 231Introduction : Biopharmaceuticals

Lecture 232Classification of Biopharmaceutical

Lecture 233Important Concept regarding Biopharmaceuticals

Lecture 234Introduction to Biologics and Biosimilar | Key differences | Concept of Reference Product

Lecture 235Key features of Biologic | Differences in Chemical Drug Vs. Biologic Drugs

Lecture 236Principle of Naming of Biologic | Understanding on MAB naming system

Lecture 237Global Biopahrma Market Trends

Lecture 238Recombinant protein

Lecture 239Monoclonal Antibodies Vs. Polyclonal Antibodies

Lecture 240Monoclonal Antibodies

Lecture 241Synthetic Immunomodulators

Lecture 242Production of Monoclonal Antibodies

Lecture 243Cytokines

Lecture 244Interferon

Lecture 245Erythropoiesis-stimulating agent

Lecture 246Vaccine development and approval Process

Lecture 247Biosimilar Development Process

Lecture 248Strategic Consideration for Biosimilar Development

Lecture 249Bio-Manufacturing Process Information

Lecture 250Studies required for approval of biosimilar

Section 7Medical Device - Strategic Management - US Market

Lecture 251US Medical Devices Market Insight

Lecture 252Definition of Medical Devices

Lecture 253Classification of Medical Devices

Lecture 254Medical Devices Classification : Work File

Lecture 255Medical Device Development to Commercialization Process | Understanding Key Stages and respective stage level activities | Important MDR terminologies

Lecture 256510k - Pre-market Notification

Lecture 257Predicate Devices | Substantially Equivalent (SE)

Lecture 258Understanding on 510k | Types of the 510k | Timeline | Difference with PMA

Lecture 259FDA decision making process for different classes of 510k applications

Lecture 260Review Test

Lecture 261Premarket approval (PMA) application

Lecture 262Differences between 510k VS. PMA

Lecture 263Data Requirements for A Premarket Approval (PMA) application

Lecture 264PMA Post Submission - Management of CRL - Timeline and Strategic Planning

Lecture 265Labeling Requirement for Medical Devices

Lecture 266Investigational Device Exemption | Device Clinical Research | Early/Expanded Access of Medical Devices | Q-Sub | IDE Submission Requirements

Lecture 267Medical Devices Development to Commercialization Stages | Devices Clinical Trial | Stages | Critical differences with pharmaceutical clinical trial

Lecture 268Medical Devices Post Approval Variations | PMA supplement | PMA amendments | Variation Management Strategic Planning

Lecture 269Unapproved use of Medical Devices

Lecture 270DeNovo Petition - Types of DeNovo Pathways | Details of Review Process | Strategic Planning

Lecture 271Humanitarian Device Exemption (HDE)

Lecture 273Combination Product RFD Designation Process | Importance | Timeline | Outcome Management

Lecture 274Combination Products Pre-market Approval Process | Lead centers | Concept of Primary Mode of Action | Strategic Submission Pathways

Section 8EU Medical Device - Strategic Insight

Lecture 275EU MDR Classification

Lecture 277EU MDR | Annexes | Key notes

Lecture 279EU MDR Guideline | EU MDR - Annexes

Lecture 280EU MDR Conformity Assessment procedure | Assessment of various classes and types of the devices | Key points to consider | Conformity assessment master chart

Lecture 281EU MDR Authorized Representatives | Mandate | Role and Responsibilities

Lecture 282Medical Device Technical File

Lecture 283Medical Device Dossier Preparation | Section Wise Dossier Preparation | Key Requirements regarding dossier | Points to note regarding each section of the dossier

Lecture 284Quality Management System (QMS) for medical devices company

Lecture 285Quality Risk Management | ICH Q9 | ISO 14971 | Principle of Risk Management

Lecture 286Comparing Medical Device Regulations | 510k Submission | Technical File | Design History File | Design Master File

Lecture 287Medical Device Essential Principle Checklist | Documentation | Open file

Lecture 288Implant Card | Regulatory Importance | Content | How to design

Lecture 289Medical Device Labeling Guideline | General Principles | Wherever applicable (specific) Labeling contents

Lecture 290Instruction for Use (IFU) | Design and Development of IFU

Lecture 291UDI | Different Component | How to design

Section 9Pharmacovigilance and Safety Management

Lecture 294Introduction to ADR | Definition | Importance of ADR management | Classification | Prevention of ADR

Lecture 295Terminologies related to ADR

Lecture 296ADR Reporting System | ADR information loop | ADR reporting system in various countries

Lecture 297DoTS

Lecture 2984 Elements of AEs

Lecture 299ADR Seriousness Determination

Lecture 300ADR Reporting Limitations

Lecture 301ADR Detection - Pre Marketing Vs. Post Marketing Trial

Lecture 302PSUR

Lecture 303Pharmacovigilance Application Path

Lecture 304Pharmacovigilance Risk Management

Lecture 305REMS Strategic Planning

Lecture 306Coding and ADR | MedDRA Principle of ADR Coding | Level of terms | Case Study

Lecture 307MedDRA Coding | Level of terms | Multi Axial Terminology | Practical Example Case Discussion

Lecture 310Signal Detection | Process | Different Types of Signal Detection Methods

Lecture 311Signal Detection in post-marketing surveillance

Lecture 312Pharmacovigilance Framework

Lecture 313Corporate Pharmacovigilance Program

Lecture 314National Pharmacovigilance Program

Lecture 315 Pharmacovigilance Software

Lecture 316ICSR in E2B Format | E2B(R3)

Lifesceience business, Lifesceience consultant, Lifesceience consulting, Lifesceience consulting management

Life Science Business Consulting

Download Course Catalogue

Your form has been submitted

Request for Course Demo Session

Your form has been submitted

Introduction

Features

Related Courses

About Life Science Consulting

Who should attend this course?

Key details about the course:

Features of Life Science Consulting Business Training Course

Case Based Learning

Few of the similar courses

What is Life Science Consulting?

Your form has been submitted

Life Science Business Consulting

Please sign in first

Not a member?

Download Course Catalogue

Your form has been submitted

Request for Course Demo Session

Your form has been submitted

Introduction

Features

Related Courses

About Life Science Consulting

Who should attend this course?

Key details about the course:

Features of Life Science Consulting Business Training Course

Case Based Learning

Few of the similar courses

What is Life Science Consulting?